- Home
- CWBC vs LRMR Comparison
CWBC vs LRMR Comparison
Compare CWBC & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWBC
- LRMR
- Stock Information
- Founded
- CWBC 1989
- LRMR N/A
- Country
- CWBC United States
- LRMR United States
- Employees
- CWBC N/A
- LRMR N/A
- Industry
- CWBC Major Banks
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- CWBC Finance
- LRMR Health Care
- Exchange
- CWBC Nasdaq
- LRMR Nasdaq
- Market Cap
- CWBC 395.8M
- LRMR 332.1M
- IPO Year
- CWBC 1996
- LRMR N/A
- Fundamental
- Price
- CWBC $21.54
- LRMR $3.58
- Analyst Decision
- CWBC Buy
- LRMR Strong Buy
- Analyst Count
- CWBC 3
- LRMR 7
- Target Price
- CWBC $21.67
- LRMR $16.71
- AVG Volume (30 Days)
- CWBC 74.1K
- LRMR 1.7M
- Earning Date
- CWBC 10-16-2025
- LRMR 11-05-2025
- Dividend Yield
- CWBC 2.24%
- LRMR N/A
- EPS Growth
- CWBC 309.48
- LRMR N/A
- EPS
- CWBC 1.78
- LRMR N/A
- Revenue
- CWBC $138,038,000.00
- LRMR N/A
- Revenue This Year
- CWBC $31.79
- LRMR N/A
- Revenue Next Year
- CWBC $9.42
- LRMR N/A
- P/E Ratio
- CWBC $12.01
- LRMR N/A
- Revenue Growth
- CWBC 45.29
- LRMR N/A
- 52 Week Low
- CWBC $15.57
- LRMR $1.61
- 52 Week High
- CWBC $22.89
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- CWBC 56.77
- LRMR 41.59
- Support Level
- CWBC $21.29
- LRMR $3.16
- Resistance Level
- CWBC $21.65
- LRMR $4.50
- Average True Range (ATR)
- CWBC 0.48
- LRMR 0.29
- MACD
- CWBC 0.03
- LRMR -0.08
- Stochastic Oscillator
- CWBC 68.02
- LRMR 30.85
About CWBC Community West Bancshares
Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.